Marc Stad - 07 Dec 2021 Form 4 Insider Report for Dragoneer Growth Opportunities Corp. II

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Dec 2021, 14:47:13 UTC
Prior SEC filing
02 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Marc Stad, /s/ Pat Robertson, Attorney-in-Fact Marc Stad

Key filing fact

Marc Stad filed Form 4 for Dragoneer Growth Opportunities Corp. II on 10 Dec 2021.

Key facts

  • This page summarizes Marc Stad's Form 4 filing for Dragoneer Growth Opportunities Corp. II.
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Dec 2021, 14:47.

Change

  • Previous filing in this sequence was filed on 02 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVT transaction

Class A ordinary shares

Award

Transaction value
Shares
+5,000,000
Change %
Price
Shares after
5,000,000
Date
07 Dec 2021
Ownership
See footnote
Footnotes
F1, F2
CVT transaction

Class B ordinary shares

Other

Transaction value
Shares
-6,600,000
Change %
-50%
Price
Shares after
6,600,000
Date
07 Dec 2021
Ownership
See footnote
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Marc Stad is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

In connection with the consummation of the transactions contemplated by the Issuer's Forward Purchase Agreement dated October 29, 2020, by and between Dragoneer Growth Opportunities Corp. II ("Dragoneer") and Dragoneer Funding II LLC ("Dragoneer Funding II") (the "FPA"), Dragoneer Funding II purchased 5,000,000 Class A ordinary shares of Dragoneer, par value $0.0001 per share, from Dragoneer at a price of $10.00 per share and assigned them to Dragoneer Funding II-A LLC ("Dragoneer Funding II-A"), an affiliate of Dragoneer Funding II.

Footnote F2

The ultimate managing member of Dragoneer Funding II is controlled by Marc Stad. Mr. Stad disclaims beneficial ownership over the securities reported herein, except to the extent of his pecuniary interest therein.

Footnote F3

Includes 6,600,000 Class B ordinary shares of Dragoneer, par value $0.0001 per share (the "Founder Shares"), held in the name of Dragoneer Growth Opportunities Holdings II (the "Sponsor"). Marc Stad is the sole member of the ultimate general partner of Dragoneer Interco Holdings LP, which is the ultimate manager of Sponsor. As a result of the foregoing, Mr. Stad may be deemed to beneficially own the Founder Shares. Mr. Stad disclaims beneficial ownership over any of the Founder Shares other than to the extent of any pecuniary interest he may have therein, and the inclusion of the Founder Shares in this report shall not be deemed an admission of beneficial ownership of the Founder Shares.

SEC remarks

This "Exit" Form 4 is voluntarily filed to report that the Marc Stad is no longer serving in the role as the Company's director and chief executive officer, effective as of December 8, 2021, and therefore is no longer subject to Section 16 reporting. Mr. Stad did not have any other transactions in the Issuer's securities during the time that he was a Section 16 reporting person other than those previously disclosed in Initial Statement of Beneficial Ownership of Securities on Form 3, filed on November 16, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .